Best Health Care Grants in American Samoa

The DoW Ovarian Cancer Clinical Trial Award, funded by the U.S. Army Medical Command, aims to accelerate the implementation of clinical trials that significantly impact ovarian cancer treatment. This award supports diverse trial designs, from early proof-of-concept studies to large-scale efficacy trials, evaluating innovative drugs, biologics, and technologies. By fostering research in this critical area, the program seeks to enhance patient outcomes and advance the understanding of ovarian cancer management.

The FY26 Breast Cancer Research Program (BCRP) Breakthrough Award Level 3 supports transformative research aimed at significant advancements in breast cancer treatment. Applicants must address key challenges outlined by the program, ensuring their proposals demonstrate potential for impactful breakthroughs. This funding mechanism, which permits small-scale clinical trials, emphasizes collaboration by requiring research teams to include two breast cancer consumer advocates and allows for a single Principal Investigator or two partnering PIs.

The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award aims to support impactful research addressing critical needs in ovarian cancer and patient care. It requires a robust research plan with preliminary data and allows for studies across all research phases, excluding clinical trials. A unique Partnering Principal Investigator option encourages collaboration between two PIs to enhance research outcomes beyond individual efforts, promoting innovation in the field of ovarian cancer.

The DoW Ovarian Cancer Pilot Award fosters innovative research that challenges existing paradigms in ovarian cancer. It aims to propel groundbreaking discoveries and advancements in the field. Notably, the award prioritizes originality over scientific merit alone, ensuring that innovative ideas are at the forefront. The application process includes a blinded pre-application screening to maintain confidentiality and integrity, encouraging fresh perspectives in ovarian cancer research.

The FY26 Breast Cancer Research Program's Transformative Breast Cancer Consortium Award fosters significant collaborations that aim to revolutionize care for individuals affected by breast cancer. This award supports a multidisciplinary consortium of leading scientists, clinicians, and advocates to tackle major challenges in breast cancer research. Proposals must address at least one of the program's overarching challenges and demonstrate a transformative impact that cannot be achieved by individual investigators alone.

The FY26 Hearing Restoration Research Program (HRRP) Focused Research Award (FRA) aims to enhance drug discovery and therapeutic development for hearing restoration following military-related auditory injuries. The award supports preclinical and clinical studies aligned with HRRP focus areas. It features two funding levels, including a Partnering Principal Investigator option, and evaluates proposals based on research rationale, strategy, impact, and personnel. Notably, it excludes funding for clinical trials, tinnitus, and vestibular research.

The DoW Spinal Cord Injury Translational Research Award supports innovative research to transform promising spinal cord injury findings into clinical applications. It features an Early-Career Partnership Option, requiring at least one early-career principal investigator. Collaborations with SCI community partners are essential for providing guidance throughout the project. This funding opportunity aims to enhance the effectiveness of spinal cord injury interventions and improve patient outcomes.

The FY26 Multiple Sclerosis Research Program Exploration – Hypothesis Development Award supports innovative, high-risk research in the MS field. It aims to establish a foundation for future scientific inquiries through well-formulated hypotheses and strong study designs. This award features options for both Established and New Investigators, the latter supporting early-career faculty. Applications must focus on at least one of the specified EHDA areas, fostering groundbreaking advancements in MS research.

The FY26 Multiple Sclerosis Research Program (MSRP) Investigator-Initiated Research Award supports innovative research that aims to enhance understanding and treatment of Multiple Sclerosis (MS). This award encourages projects at any research phase, excluding clinical trials, and requires relevant preliminary or published data. Unique options are available for both Established and New Investigators, fostering early-career researchers. Successful applications must address specified focus areas, contributing significantly to MS knowledge and patient care.

The FY26 Multiple Sclerosis Research Program (MSRP) Early Investigator Research Award provides vital opportunities for early-career researchers to engage in MS-focused studies under mentorship. This award encourages innovative research projects that address key questions in Multiple Sclerosis, fostering the development of the next generation of MS researchers. Applicants must demonstrate their project’s alignment with MSRP focus areas, ensuring a meaningful contribution to the field.

The FY26 Spinal Cord Injury Research Program Clinical Translation Research Award funds innovative clinical research aimed at bridging the gap to larger clinical trials. It focuses on accelerating the application of new techniques and improving patient outcomes through effective diagnosis and rehabilitation strategies. Key features include an Early-Career Partnership Option for principal investigators and a requirement for community partner involvement, ensuring collaborative research that meets real-world needs.

The FY26 Spinal Cord Injury Research Program Clinical Trial Award supports innovative clinical trials aimed at significantly improving spinal cord injury treatment. This funding opportunity encourages collaboration by allowing two Principal Investigators, including an early-career investigator, to drive the research forward. Applicants must partner with at least two SCI community members, ensuring that the project is informed by lived experiences and community needs throughout its development and implementation.

The FY26 Multiple Sclerosis Clinical Trial Award facilitates rapid clinical trials aimed at enhancing treatment for multiple sclerosis. It offers two funding levels: Level 1 supports small-scale trials to demonstrate feasibility, while Level 2 funds larger trials assessing safety and efficacy. All applications must include preliminary data relevant to the proposed trials. This initiative is crucial for advancing innovative therapies and improving outcomes for patients with multiple sclerosis.

The DoW Lupus Transformative Vision Award supports innovative research aimed at improving the health-related quality of life for individuals with lupus. This funding is designed for projects that demonstrate near-term impact and must align with the fiscal year 2026 focus areas. Applications require preliminary data and involvement of a lupus consumer advocate. Up to three Principal Investigators can collaborate, but only one can submit a pre-application. Clinical trials are permitted, while animal studies are not.

The FY26 Spinal Cord Injury Research Program (SCIRP) Investigator-Initiated Research Award (IIRA) supports innovative research aimed at enhancing patient care and quality of life for individuals with spinal cord injuries. This award encourages collaboration, allowing an Early-Career Partnership Option for two Principal Investigators, where one must be an early-career investigator. Focused on impactful research from basic to translational science, this opportunity is crucial for advancing SCI knowledge and interventions.

The DoW Lupus Idea Award supports high-risk, innovative research aimed at significant advancements in lupus treatment. Eligible early-career investigators can apply for this funding, which emphasizes the potential for groundbreaking discoveries without the necessity of preliminary data. The award focuses on specific research areas defined for FY26, and applicants must detail future directions. Importantly, one individual may only submit one application per award mechanism, allowing a maximum of four applications to the FY26 LRP.

The NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) aims to foster the development of promising audiologists through comprehensive postdoctoral research experiences. This funding opportunity supports individuals in biomedical, behavioral, or clinical sciences, helping them become independent researchers. The deadlines for applications span from June 2024 to May 2027, ensuring ample time for preparation and submission.

The FY26 Peer Reviewed Medical Research Program Clinical Trial Award promotes the swift initiation of impactful clinical trials for diseases outlined in specific topic areas. It offers two application categories: Clinical Trial Only and Clinical Trial with Planning Phase, supporting various funding levels based on trial phases and participant counts. The total funding of approximately $94.5M aims to support up to 9 applications, with a maximum award period of 4 years, ensuring significant advancements in medical research.

The FY26 Peer Reviewed Medical Research Program's Platform Clinical Translation Award facilitates early-phase clinical trials for innovative healthcare technologies, catering to the needs of military Service Members, Veterans, and their Families. The program allows collaborations among multiple Principal Investigators and mandates an external advisory board with patient advocate involvement. Approximately $30M is allocated to fund two applications, each capped at $15M, over a maximum period of four years, with funding contingent on performance milestones.

The Family Unification Program (FUP) aims to assist families and youth at risk of homelessness by providing Housing Choice Voucher (HCV) assistance. It targets families facing housing issues that could lead to out-of-home placement for children and youth aged 18-24 who have aged out of foster care. The program offers flexible voucher durations, with extensions available under specific conditions, ensuring support for those in need of stable housing.

The Craft Research Fund Grant, initiated in 2005, is a key program supporting scholarly craft research in the U.S. It funds researchers and curators exploring craft history and theory, with a focus on projects that reveal new insights into craft practices, relationships between hand-made and digital technologies, and global contexts for American craft. The grant aims to encourage innovation and interdisciplinary approaches in the field, while prioritizing applications from underrepresented populations.

The US Dept. of Health & Human Services, through the National Institutes of Health (NIH), is renewing the Notice of Funding Opportunity (NOFO) PAR-23-237 to support established biomedical data repositories and knowledgebases. This funding aims to sustain impactful resources that address the needs of the biomedical research community. Applications for this phase must demonstrate prior scientific impact and the potential for continued benefit to the community, while no new applications are being solicited at this time.

The NIH's TALK initiative aims to enhance clinical practices for late talking children by funding research to identify early signs of language delays. This NOFO focuses on developing evidence-based strategies for screening and supporting children and their families. It targets children over 18 months who are not meeting language milestones, particularly those at higher risk due to various factors. Collaborative research efforts are encouraged to ensure effective identification and intervention.

The National Biomedical Research Centers (NBRCs) aim to enhance biomedical research by providing advanced equipment, scientific expertise, and innovative human-based models. Supported by NIH and other federal agencies, this initiative focuses on reducing reliance on live animal models through the development of New Approach Methodologies (NAMs). The program invites applications that propose actionable plans to refine and replace animal use, promoting innovative research at centers with existing nonhuman primate colonies.

The U.S. Department of Housing and Urban Development (HUD) is inviting eligible organizations to submit unsolicited research proposals targeting key areas like housing affordability and homelessness. This initiative aims to foster high-quality research that informs housing policies and programs. Projects must secure matching funds of at least 50% of the total cost and align with HUD's research priorities to qualify for cooperative agreements, ensuring ongoing collaboration throughout the research process.

The Lead Hazard Reduction Grant Program aims to protect children under six from lead poisoning by funding comprehensive programs that identify and control lead-based paint hazards in eligible housing. This initiative supports states, Native American Tribes, and local governments to undertake necessary actions. Additionally, Healthy Homes Supplemental funding is available to address other health-related housing hazards, ensuring a holistic approach to occupant safety in homes affected by lead hazards.

The Older Adults Home Modification Grant Program aims to assist nonprofit organizations, governments, and housing authorities in making essential modifications to homes for low-income seniors. By focusing on safety and accessibility, the program seeks to reduce fall risks, enhance general safety, and improve seniors' ability to live independently. This initiative promotes aging in place, allowing seniors to remain in their homes rather than transition to nursing facilities, thereby fostering a sense of community and well-being.